|
 |
| Victor J. Bernet, MD Secretary/Chief Operating Officer |
Secretary's Report to the ATA Membership Victor J. Bernet, M.D.
29 October 2019
First, let me take the opportunity to offer our members a hearty welcome to Chicago, Illinois for the 89th Annual Meeting of the American Thyroid Association. The Program Committee, capably led by Mona Sabra and Antonio Di Cristofano, has put together an exceptional meeting that we expect will be informative as well as engage the many interests of our diverse membership. ATA committee and task force meetings are being held on Wednesday from 2:45-4:00 pm. We ask membership to be present at 5 pm for the Welcome Remarks and Opening as ATA leadership will be presenting highlights of the 2019-2022 Strategic Plan. The opening session Wednesday afternoon is entitled "Recent Developments and Future Challenges in Thyroidology" which will consist of clinical, basic science and surgical presentations. Throughout the meeting, there will be a combination of presentations to include plenary and award lectures, symposia and meet the professor sessions as well as Early Riser symposia and Expo Theater activities. Special satellite symposia will feature the 3rd Annual Pediatric Thyroid Forum and the ATA/ETA/BTA Virtual Symposium on Evidence Based Use of T3 + T4 Combinations. As usual, the Ridgway Trainee Conference will be in full swing under the supervision of Trainees and Career Advancement Committee led by Jacqueline Kung and Tracy Tylee. The ATA will host 339 trainees: 204 clinical trainees, 48 surgery trainees and 87 early career basic scientists. An important offering which is fully enrolled is the ATA Endocrine Neck Advanced Ultrasound Course co-chaired by Susan Mandel and Kevin Brumund. We have record-breaking registration numbers at the time of this report which are standing at 1500+ with regular abstract submissions at 482 (a new record!!) and 78 short call abstracts.
2018-2019 Summary Report
Another ATA governance year has passed and our beloved annual meeting is here! The ATA continues to be a very vibrant association with significant membership dedication and involvement in a growing number of ATA related activities. At present membership stands at 1807 which includes 1084 endocrinologists, 218 endocrine surgeons, 150 otolaryngologists. We have 899 Active members, 347 Corresponding, 68 Transitioning Associate (to Active and Corresponding), 25 Advanced Thyroid Professionals, 317 Associate (represent physicians in training), 42 Senior and 109 Emeritus. This year there were 22 standing committees as well as up to 10 task forces to include 4 clinical guidelines task forces (Anaplastic Thyroid Cancer, Differentiated Thyroid Cancer, Pediatric Thyroid Cancer, Thyroid Nodules) as well as 5 editorial boards (Thyroid®, Clinical Thyroidology®, VideoEndocrinology, Clinical Thyroidology® for the Public, and the Internet Communications Committee for the ATA website). Changes for next year include the launch of the Diversity, Equity and Inclusion Task Force to be co-chaired by Ernest Asamoah and Regina Castro, while the Ethics Advisory Committee will be dissolved with members with an interest in ethics being deployed to serve within our various committees.
|
|
|
Meet the Thyroid Research Grant Recipients 2019
The ATA® is committed to supporting research into better ways to diagnose and treat thyroid disease. The generosity of members, patients, industry, and donors in the workplace has enabled the ATA® to fund 105 thyroid research grants totaling over $2.8 million since the inception of the Research Fund. In addition, the ATA® rigorously manages the selection of research projects and distribution of over $2.9 million to date generously donated to the ATA® specifically for research grants from ThyCa: Thyroid Cancer Survivors' Association, Inc. and Bite Me Cancer.
Meet the Thyroid Research Grant Recipients 2019
|
|
|
ATA Corporate Leadership Council (CLC)
The ATA Corporate Leadership Council (CLC) continues to engage enduring and new industry partner interests. Annually, the ATA hosts an in-person CLC meeting during the ATA annual meeting with our CLC partners and ATA leadership The ATA works with partners to identify projects and opportunities of interest for collaboration in support of our mutual goals and missions . Current CLC partner companies are: AbbVie, Acella Pharmaceuticals, Eisai, Exelixis, Genzyme-Sanofi, Ethicon, Horizon Therapeutics, Medtronic, Mary Ann Liebert, Spectrix Therapeutics. CLC members will be identified at the ATA annual meeting by a special placard displayed at their booth.
|
|
|
SAVE THE DATE for ATA 2020 meetings
Personalized Approach to Thyroid Disorders
American Thyroid Association® 2020 Satellite Symposium
Co-chairs: Laura Boucai and Francesco Celi
March 27, 2020, 1:00 PM – 5:30 PM
Moscone Convention Center, San Francisco, California
Just prior to the start of ENDO 2020
Controversies in Thyroidology
Spring 2020 Clinical Meeting of the American Thyroid Association®
Co-chairs: Whitney Goldner and Kepal Patel
May 28-30, 2020
Westin New York Times Square
New York, NY
16th International Thyroid Congress (ITC)
Hosted by the Asia & Oceania Thyroid Association (AOTA)
September 8-13, 2020
Xi'an, China
Website: https://www.thyroid.org/16th-itc/
|
|
|
|
|
VE - Volume 6 Issue 3
available online through members only
Editor-in-Chief
William B. Inabnet III, MD, FACS
|
|
|
|
|
|
A publication of the American Thyroid Association®
|
|
|
|
